𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Added Clinical Benefit of Incorporating 2-Deoxy-2-[18F]Fluoro-D-Glucose with Positron Emission Tomography into the Clinical Evaluation of Patients with Cognitive Impairment

✍ Scribed by Daniel H.S Silverman; Jeffrey L Cummings; Gary W Small; Sanjiv S Gambhir; Wei Chen; Johannes Czernin; Michael E Phelps

Book ID
117795623
Publisher
Springer-Verlag
Year
2002
Tongue
English
Weight
242 KB
Volume
4
Category
Article
ISSN
1536-1632

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Predicting the prognoses of breast carci
Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose
✍ Masaki Oshida; Kimiichi Uno; Masato Suzuki; Takeshi Nagashima; Hideyuki Hashimot πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 274 KB πŸ‘ 2 views

## BACKGROUND. Positron emission tomography (PET) with 2-deoxy-2-fluoro[ 18 F]-Dglucose (FDG) can provide quantitative information about tumor glucose metabolism. The prognostic value of this technique was evaluated for breast carcinoma patients. ## METHODS. FDG PET was performed on 70 patients w